Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Wei Ye, Zhonghua Song, Zhongkun Lin

Open source

DOI
10.1155/2022/5067402
Published
2022-09-24
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/5067402,
  title = {Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer},
  author = {Wei Ye and Zhonghua Song and Zhongkun Lin},
  year = {2022},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2022/5067402},
  url = {https://doi.org/10.1155/2022/5067402}
}

RIS

TY  - JOUR
TI  - Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
AU  - Wei Ye
AU  - Zhonghua Song
AU  - Zhongkun Lin
PY  - 2022
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2022/5067402
UR  - https://doi.org/10.1155/2022/5067402
ER  - 

APA

Ye, W., Song, Z., & Lin, Z. (2022). Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/5067402

Source records